Alendronic Acid Oral Solution
Alendronic Acid is an oral liquid medicine used to treat osteoporosis.
Alendronic Acid Suspension is indicated for the following:
Treatment of post-menopausal osteoporosis.
Alendronic acid reduces the risk of vertebral and hip fractures.
Summary of Product Characteristics
Read this summary of product characteristics for further information about Alendronic Acid Oral Solution. Click below to navigate to the EMC.
Patient Information Leaflet
Read this patient information leaflet about Alendronic Acid Oral Solution, what it’s used for and possible side effects. Click below to navigate to the EMC.
Alendronic Acid Oral Solution
| Click here for Audio Version | |
| Flavour | Orange |
| Storage Conditions | Do not store above 25°C |
| Sucrose Free | |
| Shelf Life (Closed Bottle) | 24 months |
| PIP Code | 116-0597 |
| EAN Code | 50-16119-22669-4 |
| Sodium Levels | None |
| Ethanol Concentration | 115mg/100ml |
Downloads
Adverse Events
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk
Adverse events should also be reported to Rosemont at 0113 244 1400 or pharmacovigilance@rosemontpharma.com.
Contact us
For further product information and pricing please use the form below and a member of the team will be in touch
Stay updated via our App
A new Rosemont Pharmaceuticals App for Healthcare Professionals is launching soon.
Related Products
